CN113694166A - Toxin-removing medicine for blood and liver to expel toxin and preparation method thereof - Google Patents
Toxin-removing medicine for blood and liver to expel toxin and preparation method thereof Download PDFInfo
- Publication number
- CN113694166A CN113694166A CN202111154028.7A CN202111154028A CN113694166A CN 113694166 A CN113694166 A CN 113694166A CN 202111154028 A CN202111154028 A CN 202111154028A CN 113694166 A CN113694166 A CN 113694166A
- Authority
- CN
- China
- Prior art keywords
- parts
- toxin
- liver
- blood
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003053 toxin Substances 0.000 title claims abstract description 84
- 231100000765 toxin Toxicity 0.000 title claims abstract description 84
- 210000004185 liver Anatomy 0.000 title claims abstract description 71
- 210000004369 blood Anatomy 0.000 title claims abstract description 64
- 239000008280 blood Substances 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 title claims description 27
- 235000021419 vinegar Nutrition 0.000 claims abstract description 50
- 239000000052 vinegar Substances 0.000 claims abstract description 50
- 241000218176 Corydalis Species 0.000 claims abstract description 25
- 239000006210 lotion Substances 0.000 claims abstract description 24
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 12
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 9
- 229940010454 licorice Drugs 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 22
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 241000202807 Glycyrrhiza Species 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 108700012359 toxins Proteins 0.000 abstract description 59
- 230000000694 effects Effects 0.000 abstract description 12
- 231100000331 toxic Toxicity 0.000 abstract description 8
- 230000002588 toxic effect Effects 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 206010027439 Metal poisoning Diseases 0.000 abstract description 3
- 102000003929 Transaminases Human genes 0.000 abstract description 3
- 108090000340 Transaminases Proteins 0.000 abstract description 3
- 208000019425 cirrhosis of liver Diseases 0.000 abstract description 3
- 208000010501 heavy metal poisoning Diseases 0.000 abstract description 3
- 208000002672 hepatitis B Diseases 0.000 abstract description 3
- 235000019605 sweet taste sensations Nutrition 0.000 abstract description 3
- 206010019851 Hepatotoxicity Diseases 0.000 abstract description 2
- 230000001476 alcoholic effect Effects 0.000 abstract description 2
- 231100000304 hepatotoxicity Toxicity 0.000 abstract description 2
- 230000007686 hepatotoxicity Effects 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 210000002700 urine Anatomy 0.000 abstract description 2
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 230000007882 cirrhosis Effects 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 238000001784 detoxification Methods 0.000 description 14
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 8
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 244000303040 Glycyrrhiza glabra Species 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 3
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 3
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000020980 bad eating habits Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a toxin removing lotion for removing toxin from blood and liver, which comprises the following components in parts by weight: 10-20 parts of vinegar radix bupleuri, 10-20 parts of herba Ophioglossi, 10-20 parts of fried fructus Gardeniae, 10-20 parts of vinegar rhizoma corydalis, 10-20 parts of Salvia miltiorrhiza, 10-20 parts of radix Curcumae, 5-15 parts of radix et rhizoma Rhei preparata and 3-8 parts of licorice. The invention adopts pure Chinese herbal medicine components, has simple preparation and fragrant and slightly sweet taste, is drunk after being mixed with water, can discharge toxins out of the body through urine after being drunk, has no toxic or side effect, can discharge the toxins in blood and liver, treats various liver diseases such as hepatotoxicity, cirrhosis, viral hepatitis B, alcoholic liver and heavy metal poisoning, and can effectively reduce liver transaminase and tumor markers.
Description
Technical Field
The invention relates to the field of traditional Chinese medicine application, in particular to a toxin removing medicine for removing toxin of blood and liver and a preparation method thereof.
Background
The liver is the most important organ for detoxification of human body, and toxic substances produced by external or internal metabolism are all detoxified in the liver to become nontoxic or soluble substances. In traditional Chinese medicine, a lot of toxins exist in human bodies, substances which can not be discharged outside the human bodies and spirit in time and can generate adverse effects can be called as 'toxins', and the toxins are accumulated in the five internal organs, so that the aging of the five internal organs, particularly the liver, can be accelerated, the health of the human bodies is influenced, and various diseases are caused. Some food products are not toxic, but when such cold-or hot-natured food is consumed too much, it becomes "toxic". In addition, the deviation from normal living habits, such as long-term drinking, overstrain, staying up all night, bad eating habits, and the like, can cause "poison" due to excessive, and threaten the health of human bodies. Many diseases are caused by the accumulation of toxins in the body, for example: hepatitis B, liver cirrhosis, alcoholic liver disease, hepatotoxicity, heavy metal poisoning and the like, which have serious threats to the health of people.
Due to the over-development of human beings in recent decades, the whole nature is polluted by a lot of pollutants, such as air, food and the like, especially super-pollution of pesticides, chemical raw materials, nuclear resources and the like, and the pollutants invade the human body and generate toxins in the human body. The use of a large amount of antiviral and hormonal drugs in modern medical technology can lead to the accumulation of a large amount of toxic and harmful materials in the body and blood of a patient. The diet and life irregularity of people cause various diseases to be propagated and increased in multiples, and the long-term intake and accumulation of self toxins cause the liver to be heavily stressed, possibly cause various fatal diseases, and naturally reduce the average life of people.
At present, pure Chinese herbal medicines in the traditional Chinese medicine field in the market have blanks in blood and liver detoxification.
Disclosure of Invention
The application aims to solve the technical problems and provides a toxin removing lotion for removing toxin of blood and liver.
The application is realized by the following technical scheme:
a toxin removing medicine for removing toxin of blood and liver is characterized in that: the toxin removing lotion for blood and liver toxin removal comprises the following components in parts by weight: 10-20 parts of vinegar radix bupleuri, 10-20 parts of herba Ophioglossi, 10-20 parts of fried fructus Gardeniae, 10-20 parts of vinegar rhizoma corydalis, 10-20 parts of Salvia miltiorrhiza, 10-20 parts of radix Curcumae, 5-15 parts of radix et rhizoma Rhei preparata and 3-8 parts of licorice.
The vinegar radix bupleuri in the toxin clearing serum for expelling the toxin from the blood and the liver is bitter in taste and slightly cold in nature, enters liver and gallbladder channels, and has the effects of harmonizing exterior and interior, soothing liver and invigorating yang. An arrow is bitter and sweet in taste and slightly cold in nature, enters liver meridian, and has the effects of clearing away heat and toxic materials, promoting blood circulation and removing blood stasis. Gardenia is bitter in taste and cold in nature, enters heart, lung and triple energizer meridians, and has the effects of clearing heat, purging fire and cooling blood. Vinegar corydalis tuber is pungent and bitter in taste and warm in nature, enters liver, stomach, heart, lung and spleen channels, and has the effects of promoting blood circulation, benefiting qi and relieving pain. The salvia miltiorrhiza is bitter in taste and slightly cold, enters heart and liver channels, and has the effects of activating blood circulation to dissipate blood stasis, stimulating menstrual flow to relieve pain, clearing away heart-fire and relieving restlessness, cooling blood and eliminating carbuncle. The radix curcumae is pungent, bitter and cold in flavor, enters liver, heart and lung channels, and has the effects of activating blood circulation, relieving pain, promoting qi circulation, relieving depression, clearing away heart-fire, cooling blood, benefiting gallbladder and removing jaundice. The prepared rhubarb is mainly used for treating swollen throat, swelling and aching gum, purging fire and removing toxicity. The liquorice has sweet taste and neutral nature, enters heart, lung, spleen and stomach channels, and has the effects of tonifying spleen and qi, clearing away heat and toxic materials, eliminating phlegm and stopping cough, relieving spasm and pain and harmonizing the medicines.
Further, the toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 12-18 parts of vinegar radix bupleuri, 12-18 parts of herba Ophioglossi, 12-18 parts of fried fructus Gardeniae, 12-18 parts of vinegar rhizoma corydalis, 12-18 parts of Salvia miltiorrhiza, 12-18 parts of radix Curcumae, 5-15 parts of radix et rhizoma Rhei preparata and 3-8 parts of licorice.
Further, the toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 10-20 parts of vinegar radix bupleuri, 10-20 parts of herba Ophioglossi, 10-20 parts of fried fructus Gardeniae, 10-20 parts of vinegar rhizoma corydalis, 10-20 parts of Salvia miltiorrhiza, 10-20 parts of radix Curcumae, 8-12 parts of radix et rhizoma Rhei preparata and 3-8 parts of licorice.
Further, the toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 10-20 parts of vinegar radix bupleuri, 10-20 parts of herba Ophioglossi, 10-20 parts of fried fructus Gardeniae, 10-20 parts of vinegar rhizoma corydalis, 10-20 parts of Salvia miltiorrhiza, 10-20 parts of radix Curcumae, 5-15 parts of radix et rhizoma Rhei preparata and 4-5 parts of radix Glycyrrhizae.
Further, the toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 12-18 parts of vinegar radix bupleuri, 12-18 parts of herba Ophioglossi, 12-18 parts of fried fructus Gardeniae, 12-18 parts of vinegar rhizoma corydalis, 12-18 parts of Salvia miltiorrhiza, 12-18 parts of radix Curcumae, 8-12 parts of radix et rhizoma Rhei preparata and 4-5 parts of licorice.
Preferably, the blood and liver toxin expelling toxin washing toxin removing toxin clearing agent comprises the following components in parts by weight: 15 parts of vinegar radix bupleuri, 15 parts of herba Ophioglossi, 15 parts of fried fructus Gardeniae, 15 parts of vinegar rhizoma corydalis, 15 parts of radix Salviae Miltiorrhizae, 15 parts of radix Curcumae, 10 parts of radix et rhizoma Rhei preparata and 5 parts of radix Glycyrrhizae.
The invention also provides a preparation method of the composition, which comprises the following steps: the raw material medicines in parts by weight are taken and directly pulverized.
The invention also provides a pharmaceutical preparation which comprises the composition.
Furthermore, the pharmaceutical preparation also comprises pharmaceutically acceptable auxiliary materials or auxiliary components.
Preferably, the dosage form of the pharmaceutical preparation is powder, and the pharmaceutical preparation is directly drunk after being brewed by 1500 ml of water.
Compared with the prior art, the method has the following beneficial effects:
the invention discloses a toxin removing medicine for blood and liver detoxification, which has the advantages of simple preparation, fragrant and slightly sweet taste, convenient drinking, toxin discharged out of body through urine after drinking, no toxic or side effect, stable and definite curative effect verified by a large amount of clinical data, and can treat liver poisoning, liver cirrhosis, hepatitis B, alcoholic liver and heavy metal poisoning, effectively reduce blood transaminase, reduce tumor markers and the like.
Detailed Description
In order to make the purpose, technical solution and beneficial effects of the present application clearer, the technical solution in the embodiment of the present invention will be clearly and completely described below with reference to the embodiment of the present invention. It is to be understood that the described embodiments are merely exemplary of some, but not all, embodiments of the invention. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
Example 1
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 10 parts of vinegar radix bupleuri, 10 parts of herba Ophioglossi, 10 parts of fried fructus Gardeniae, 10 parts of vinegar rhizoma corydalis, 10 parts of radix Salviae Miltiorrhizae, 10 parts of radix Curcumae, 5 parts of radix et rhizoma Rhei preparata and 3 parts of radix Glycyrrhizae.
A powder for removing toxic substances from blood and liver is prepared by pulverizing the above medicines into fine powder, mixing, and packaging into sealed bags with 8 g for each bag and 15 g for each bag.
Example 2
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 20 parts of vinegar radix bupleuri, 20 parts of herba Ophioglossi, 20 parts of fried fructus Gardeniae, 20 parts of vinegar rhizoma corydalis, 20 parts of radix Salviae Miltiorrhizae, 20 parts of radix Curcumae, 15 parts of radix et rhizoma Rhei preparata and 8 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 3
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 12 parts of vinegar radix bupleuri, 12 parts of herba Ophioglossi, 12 parts of fried fructus Gardeniae, 12 parts of vinegar rhizoma corydalis, 12 parts of radix Salviae Miltiorrhizae, 12 parts of radix Curcumae, 5 parts of radix et rhizoma Rhei preparata and 3 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 4
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 18 parts of vinegar radix bupleuri, 18 parts of herba Ophioglossi, 18 parts of fried fructus Gardeniae, 18 parts of vinegar rhizoma corydalis, 18 parts of radix Salviae Miltiorrhizae, 18 parts of radix Curcumae, 15 parts of radix et rhizoma Rhei preparata and 8 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 5
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 10 parts of vinegar radix bupleuri, 10 parts of herba Ophioglossi, 10 parts of fried fructus Gardeniae, 10 parts of vinegar rhizoma corydalis, 10 parts of radix Salviae Miltiorrhizae, 10 parts of radix Curcumae, 8 parts of radix et rhizoma Rhei preparata and 3 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 6
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 20 parts of vinegar radix bupleuri, 20 parts of herba Ophioglossi, 20 parts of fried fructus Gardeniae, 20 parts of vinegar rhizoma corydalis, 20 parts of radix Salviae Miltiorrhizae, 20 parts of radix Curcumae, 12 parts of radix et rhizoma Rhei preparata and 8 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 7
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 10 parts of vinegar radix bupleuri, 10 parts of herba Ophioglossi, 10 parts of fried fructus Gardeniae, 10 parts of vinegar rhizoma corydalis, 10 parts of radix Salviae Miltiorrhizae, 10 parts of radix Curcumae, 5 parts of radix et rhizoma Rhei preparata and 4 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 8
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 20 parts of vinegar radix bupleuri, 20 parts of herba Ophioglossi, 20 parts of fried fructus Gardeniae, 20 parts of vinegar rhizoma corydalis, 20 parts of radix Salviae Miltiorrhizae, 20 parts of radix Curcumae, 15 parts of radix et rhizoma Rhei preparata and 5 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 9
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 12 parts of vinegar radix bupleuri, 12 parts of herba Ophioglossi, 12 parts of fried fructus Gardeniae, 12 parts of vinegar rhizoma corydalis, 12 parts of radix Salviae Miltiorrhizae, 12 parts of radix Curcumae, 8 parts of radix et rhizoma Rhei preparata and 4 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 10
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 18 parts of vinegar radix bupleuri, 18 parts of herba Ophioglossi, 18 parts of fried fructus Gardeniae, 18 parts of vinegar rhizoma corydalis, 18 parts of radix Salviae Miltiorrhizae, 18 parts of radix Curcumae, 12 parts of radix et rhizoma Rhei preparata and 5 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
Example 11
A toxin removing lotion for removing toxin of blood and liver comprises the following components in parts by weight: 15 parts of vinegar radix bupleuri, 15 parts of herba Ophioglossi, 15 parts of fried fructus Gardeniae, 15 parts of vinegar rhizoma corydalis, 15 parts of radix Salviae Miltiorrhizae, 15 parts of radix Curcumae, 10 parts of radix et rhizoma Rhei preparata and 5 parts of radix Glycyrrhizae.
The preparation steps of the blood and liver detoxification powder are the same as example 1.
The number of people who take the blood and liver toxin-expelling tea prepared in the embodiment 11 in the consulting room of the inventor is about 1000 in recent ten years, and patients who take the tea for the blood and the liver for the corresponding treatment have no ineffectiveness and no toxic or side effect.
Case 1, a patient, in 2 months of 2010, was treated, at the age of 53.
When patients visit the clinic, a serum detection report of 1 month in 2010 is provided, the content of alpha-fetoprotein (AFP) is 15.24ng/mL, and the content of carcinoembryonic antigen (CEA) is 3.86 ng/mL. After the treatment, the ordinary type of the blood and liver detoxification powder in the example 11 is taken, a bag of the powder is soaked in boiled water every day, and the soaked liquid medicine is drunk, wherein the liquid medicine is drunk more than 1500 ml every day, and the powder is continuously taken for 2 months. Serum detection is carried out on a patient in the hospital 6, 12 days before 2010, a clinical examination report sheet of the western medicine detection institute of Sichuan university is provided, and the report sheet shows that the content of hyperthyroidism protein (AFP) in the serum of the patient is 3.64ng/mL and the content of carcinoembryonic antigen (CEA) is 0.85 ng/mL.
Case 2, Huang-Yi, woman, at the time of treatment, is 39 years old.
When patients are in a clinic, a plasma detection report is provided, the content of carcinoembryonic antigen (CEA) is 64.62ng/mL, and the content of tumor associated antigen 125 (CA 125) is 69.55 ng/mL. After the treatment, the powder for removing toxin of blood and liver in example 11 is taken, a bag of the powder is soaked in boiled water every day, and the soaked liquid medicine is drunk, wherein the liquid medicine is drunk every day, and the volume of the liquid medicine is more than 1500 ml. The plasma detection of the patient is carried out in the hospital 11/25 th before 2010, a nuclear medicine examination report of the university of Chinese medicine subsidiary hospital of Chengdu is provided, and the report shows that the content of carcinoembryonic antigen (CEA) in the plasma of the patient is 31.21ng/mL and the content of tumor-associated antigen 125 (CA 125) is 14.91 ng/mL.
Case 3, men, at the visit, was 36 years old.
The patient provides a test report form of a Ministry health service center of south China gold Sha community at Chengdu city of China for 9 and 20 days in 2010, and the content of glutamic aminotransferase in serum is 1268.6U/L. After the treatment, the enhanced powder for removing toxin of blood and liver in example 11 is taken, a bag of the powder is soaked in boiled water every day, and the soaked liquid medicine is drunk, wherein the liquid medicine is drunk more than 1500 ml every day, and the powder is continuously taken for 2 months. The patient again went to the Ministry's city's mansion southern Jinsha community health service center for serum testing in 2011, month 5 and 20, and the report sheet shows that the content of glutamic-amino transferase in the serum of the patient is 638.0U/L.
The above embodiments are provided to explain the objects, technical solutions and advantages of the present invention in further detail, and it should be understood that the above embodiments are only illustrative of the invention and are not intended to limit the scope of the present invention, and any modifications, equivalents, improvements and the like made within the spirit and principle of the present invention should be included in the scope of the present invention.
Claims (10)
1. A toxin removing medicine for removing toxin of blood and liver is characterized in that: the toxin removing lotion for blood and liver toxin removal comprises the following components in parts by weight: 10-20 parts of vinegar radix bupleuri, 10-20 parts of herba Ophioglossi, 10-20 parts of fried fructus Gardeniae, 10-20 parts of vinegar rhizoma corydalis, 10-20 parts of Salvia miltiorrhiza, 10-20 parts of radix Curcumae, 5-15 parts of radix et rhizoma Rhei preparata and 3-8 parts of licorice.
2. A toxin removing medicine for removing toxin of blood and liver is characterized in that: the toxin removing lotion for blood and liver toxin removal comprises the following components in parts by weight: 12-18 parts of vinegar radix bupleuri, 12-18 parts of herba Ophioglossi, 12-18 parts of fried fructus Gardeniae, 12-18 parts of vinegar rhizoma corydalis, 12-18 parts of Salvia miltiorrhiza, 12-18 parts of radix Curcumae, 5-15 parts of radix et rhizoma Rhei preparata and 3-8 parts of licorice.
3. A toxin removing medicine for removing toxin of blood and liver is characterized in that: the toxin removing lotion for blood and liver toxin removal comprises the following components in parts by weight: 10-20 parts of vinegar radix bupleuri, 10-20 parts of herba Ophioglossi, 10-20 parts of fried fructus Gardeniae, 10-20 parts of vinegar rhizoma corydalis, 10-20 parts of Salvia miltiorrhiza, 10-20 parts of radix Curcumae, 8-12 parts of radix et rhizoma Rhei preparata and 3-8 parts of licorice.
4. A toxin removing medicine for removing toxin of blood and liver is characterized in that: the toxin removing lotion for blood and liver toxin removal comprises the following components in parts by weight: 10-20 parts of vinegar radix bupleuri, 10-20 parts of herba Ophioglossi, 10-20 parts of fried fructus Gardeniae, 10-20 parts of vinegar rhizoma corydalis, 10-20 parts of Salvia miltiorrhiza, 10-20 parts of radix Curcumae, 5-15 parts of radix et rhizoma Rhei preparata and 4-5 parts of radix Glycyrrhizae.
5. A toxin removing medicine for removing toxin of blood and liver is characterized in that: the toxin removing lotion for blood and liver toxin removal comprises the following components in parts by weight: 12-18 parts of vinegar radix bupleuri, 12-18 parts of herba Ophioglossi, 12-18 parts of fried fructus Gardeniae, 12-18 parts of vinegar rhizoma corydalis, 12-18 parts of Salvia miltiorrhiza, 12-18 parts of radix Curcumae, 8-12 parts of radix et rhizoma Rhei preparata and 4-5 parts of licorice.
6. A toxin removing medicine for removing toxin of blood and liver is characterized in that: the toxin removing lotion for blood and liver toxin removal comprises the following components in parts by weight: 15 parts of vinegar radix bupleuri, 15 parts of herba Ophioglossi, 15 parts of fried fructus Gardeniae, 15 parts of vinegar rhizoma corydalis, 15 parts of radix Salviae Miltiorrhizae, 15 parts of radix Curcumae, 10 parts of radix et rhizoma Rhei preparata and 5 parts of radix Glycyrrhizae.
7. The method for preparing the dacDuduqing for detoxifying blood and liver as claimed in any one of claims 1 to 6, wherein the method comprises the following steps: the method comprises the following steps: the raw material medicines in parts by weight are taken and directly pulverized.
8. A pharmaceutical preparation, which is characterized by comprising the composition for detoxifying blood and liver as claimed in any one of claims 1-6.
9. The pharmaceutical formulation of claim 8, wherein: the components of the pharmaceutical preparation also comprise pharmaceutically acceptable auxiliary materials or auxiliary components.
10. The pharmaceutical formulation of claim 9, wherein: the dosage form of the medicinal preparation is powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111154028.7A CN113694166A (en) | 2021-09-29 | 2021-09-29 | Toxin-removing medicine for blood and liver to expel toxin and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111154028.7A CN113694166A (en) | 2021-09-29 | 2021-09-29 | Toxin-removing medicine for blood and liver to expel toxin and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113694166A true CN113694166A (en) | 2021-11-26 |
Family
ID=78662375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111154028.7A Pending CN113694166A (en) | 2021-09-29 | 2021-09-29 | Toxin-removing medicine for blood and liver to expel toxin and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113694166A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1219422A (en) * | 1998-11-03 | 1999-06-16 | 巫茂成 | Medicine for curing hepatic and gallbladder diseases |
| CN101116739A (en) * | 2007-08-14 | 2008-02-06 | 廖啟义 | Chinese traditional medicine for treating acute and chronic hepatitis |
| CN101129994A (en) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | Traditional Chinese medicine composition for treating icterus |
| CN102988906A (en) * | 2013-01-08 | 2013-03-27 | 于收 | Traditional Chinese medicine combination for treating cirrhosis |
| CN103100060A (en) * | 2013-02-18 | 2013-05-15 | 李承平 | A group of Scutellaria baicalensis and Gentian tablets used for eliminating fire |
| CN103100051A (en) * | 2013-02-04 | 2013-05-15 | 夏学文 | Traditional Chinese medicine composition for treating acute or chronic hepatitis and hepatosplenomegaly, and inhibiting liver cancer |
-
2021
- 2021-09-29 CN CN202111154028.7A patent/CN113694166A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1219422A (en) * | 1998-11-03 | 1999-06-16 | 巫茂成 | Medicine for curing hepatic and gallbladder diseases |
| CN101116739A (en) * | 2007-08-14 | 2008-02-06 | 廖啟义 | Chinese traditional medicine for treating acute and chronic hepatitis |
| CN101129994A (en) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | Traditional Chinese medicine composition for treating icterus |
| CN102988906A (en) * | 2013-01-08 | 2013-03-27 | 于收 | Traditional Chinese medicine combination for treating cirrhosis |
| CN103100051A (en) * | 2013-02-04 | 2013-05-15 | 夏学文 | Traditional Chinese medicine composition for treating acute or chronic hepatitis and hepatosplenomegaly, and inhibiting liver cancer |
| CN103100060A (en) * | 2013-02-18 | 2013-05-15 | 李承平 | A group of Scutellaria baicalensis and Gentian tablets used for eliminating fire |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN111759951A (en) | Preparation method and application of functional dendrobe coffee for dredging human gonad channel | |
| CN102908470B (en) | Chinese materia medica preparation for tonifying Yang and preparation method thereof | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN113694166A (en) | Toxin-removing medicine for blood and liver to expel toxin and preparation method thereof | |
| CN103330837A (en) | Traditional Chinese medicine composition for curing osteoporosis of menopausal women | |
| CN102727791B (en) | Medicine for treating AIDS and preparation method thereof | |
| CN106138785A (en) | One treats neurasthenic Chinese medicine composition and preparation method thereof | |
| CN104888132A (en) | Traditional Chinese medicine composition for treatment of chronic gastritis | |
| CN105853978A (en) | Method for preparing medicinal composition for treating female climacteric syndrome | |
| CN117045716B (en) | A Chinese medicine composition, preparation and preparation method for treating lumbar disc herniation | |
| CN105311602B (en) | A kind of Chinese medicine composition of prevention asthma in children | |
| CN114732882B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| Yiwen et al. | Medication Rule and Innovative Application of Oral Administration of Traditional Chinese Medicine Decoction in the Treatment of Amyotrophic Lateral Sclerosis | |
| CN106309576A (en) | Drug for treating haemorrhoids and preparation method thereof | |
| CN105727069A (en) | Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition | |
| CN106177772A (en) | A kind of herbal composite treating bladder cancer and carcinoma of prostate | |
| CN105688158B (en) | A kind of Chinese materia medica preparation and preparation method thereof for treating autoimmune liver disease | |
| CN105362966A (en) | Method for preparing traditional Chinese medicine preparation for treating fatty liver | |
| CN105311468A (en) | Traditional Chinese medicine composition for treating lymph cancer and preparation method thereof | |
| CN104623597A (en) | Medicinal composition for treating pain and fever of cancer patient and preparation method thereof | |
| CN111759917A (en) | Viscera comprehensive conditioning soup and preparation method thereof | |
| CN114504634A (en) | Clear liquid for rectal administration of children and preparation method thereof | |
| CN116036165A (en) | Traditional Chinese medicine composition for treating novel coronavirus and preparation method thereof | |
| CN118416162A (en) | Acupoint application for treating constipation with syndrome of yin deficiency and intestine dryness and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211126 |